Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society.
Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society.
复制标题
为治疗铺平道路：21 三体研究学会第二届国际会议。
DOI：
10.1159/000494231
复制
发表时间：
2019
影响因子：
1.1
通讯作者：
Busciglio,Jorge
中科院分区：
文献类型：
--
作者：
Reeves,RogerH;Delabar,Jean;Potier,Marie-Claude;Bhattacharyya,Anita;Head,Elizabeth;Lemere,Cynthia;Dekker,AlainD;DeDeyn,Peter;Caviedes,Pablo;Dierssen,Mara;Busciglio,Jorge
在过去的十年中，不同领域的一些重要研究进展使唐氏综合征（DS）研究蓬勃发展，创造了一个前所未有的机遇和巨大挑战的时代。建立一个科学框架，提取参与DS发育性智力障碍的机制，以及阿尔茨海默病的早发性成分和与该疾病相关的其他几种合并症，是科学家们现在正在使用新技术和多学科方法解决的挑战。Trisomy 21 Research Society（T21RS）成立于2014年，旨在应对这些不断变化的需求和挑战。2017年6月，T21 RS在美国芝加哥举行了第二届国际会议。有200多名科学家，倡导者，DS患者和家庭成员出席，会议成为讨论最新研究和临床进展以及DS患者及其家庭最迫切需求的论坛。
In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and considerable challenge. Building a scientific framework that distills mechanisms involved in the developmental intellectual disability of DS as well as the early-onset component of Alzheimer disease and the several other comorbidities associated with the condition is a challenge that scientists are now tackling using novel technologies and multidisciplinary approaches. The Trisomy 21 Research Society (T21RS) was founded in 2014 to address these evolving needs and challenges. In June of 2017, the T21RS held its 2nd International Conference in Chicago, USA. With more than 200 scientists, advocates, people with DS, and family members in attendance, the meeting served as a forum for the discussion of the latest research and clinical advances as well as the most compelling needs of people with DS and their families.